The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myeloma - Raab, Marc-Steffen; Thomas, Sheeba K.; Ocio, Enrique M.; Guenther, Andreas; Goh, Yeow-Tee; Talpaz, Moshe; Hohmann, Nicolas; Zhao, Sylvia; Xiang, Fang; Simon, Carl; Vanasse, K. Gary; Kumar, Shaji K. (Leukemia, 2019)
Gesehen am 22.01.2020